TP53 and neoplasm: It was estimated that 20%–25% of EOC cases are associated with the presence of pathogenic germline variants in BRCA1/211, 12 or in other genes associated with tumor suppression and/or DNA damage response (TP53, STK11, PTEN, ATM, and CHEK2).13